Virtu Financial LLC Pds Biotechnology Corp Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$3.95 - $6.58 $98,351 - $163,835	24,899 New	24,899 $124,000
Q2 2022 Aug 09, 2022	BUY	$3.05 - $6.68 $144,344 - $316,137	47,326 New	47,326 $173,000
Q4 2021 Feb 17, 2022	SELL	$7.76 - $14.35 $137,320 - $253,937	-17,696 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.33 - $17.08 $165,103 - $302,247	17,696 New	17,696 $264,000
Q2 2021 Sep 17, 2021	SELL	$4.35 - $12.86 $46,118 - $136,341	-10,602 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$2.28 - $6.81 $24,172 - $72,199	10,602 New	10,602 $48,000
Q4 2020 Feb 24, 2021	SELL	$1.91 - $2.67 $19,264 - $26,929	-10,086 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$1.67 - $4.67 $16,843 - $47,101	10,086 New	10,086 $24,000

4.32M

253K

70.4K

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $62.6M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.